
From lab to commercialization: Navigate the evolving risks of life science companies
Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding international clinical trial requirements and adapting to the rise of AI in research and product development.
In this three-part webinar series, our experts will help you identify critical insurance considerations and risk mitigation strategies at every stage of your company’s growth. Each session is designed to address a distinct challenge in the life science ecosystem—whether you're moving toward clinical trials, preparing for an IPO, or integrating AI technologies.
We’ll break down:
- Essential coverages by growth stage
- Country-specific clinical trial requirements
- Real-world risks and insurance implications of AI in life sciences
Whether you’re an early-stage biotech company or preparing for commercialization, join us to gain actionable insights and stay ahead in this dynamic industry.

Webinar 1
Navigating Risk from Lab to IPO: A Guide to Insurance for Biotech Executives
June 10th, 10am PT | 1pm ET
In this session, we’ll walk through the key insurance and risk management milestones life science companies should prepare for as they move from early funding through clinical trials, IPO, and commercialization. Learn what coverages matter most at each stage, common pitfalls to avoid, and how to build a scalable insurance strategy that supports

Webinar 2
AI In Real Life (Science): Exploring Real World Risks and Implications of Using AI in the Life Sciences Industry
July 22nd, 10am PT | 1pm ET
Explore how AI and life science products are revolutionizing technology in our upcoming webinar. Discover the unique risks these advancements pose and learn about specialized insurance solutions designed to protect businesses in this dynamic landscape.

Webinar 3
International Clinical Trials Country Requirements- What You Need To Know
August 12th, 10am PT | 1pm ET
Join us for an insightful webinar that recaps the phases of clinical trials from I to IV and delves into the latest updates on international clinical trial country requirements. Learn what to expect when securing coverage for your trial within different countries and stay ahead of the curve in clinical research.
Register